These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 22426860)

  • 1. Differential expression of coxsackievirus and adenovirus receptor on alveolar epithelial cells between fetal and adult mice determines their different susceptibility to coxsackievirus B infection.
    Sun F; Li Y; Jia T; Ling Y; Liang L; Liu G; Chen H; Chen S
    Arch Virol; 2012 Jun; 157(6):1101-11. PubMed ID: 22426860
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Primary neurons become less susceptible to coxsackievirus B5 following maturation: the correlation with the decreased level of CAR expression on cell surface.
    Ahn J; Jee Y; Seo I; Yoon SY; Kim D; Kim YK; Lee H
    J Med Virol; 2008 Mar; 80(3):434-40. PubMed ID: 18205224
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Hepatic damage caused by coxsackievirus B3 is dependent on age-related tissue tropisms associated with the coxsackievirus-adenovirus receptor.
    Liu JY; Wang SM; Chen IC; Yu CK; Liu CC
    Pathog Dis; 2013 Jul; 68(2):52-60. PubMed ID: 23620416
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Coxsackievirus B3 infection and type 1 diabetes development in NOD mice: insulitis determines susceptibility of pancreatic islets to virus infection.
    Drescher KM; Kono K; Bopegamage S; Carson SD; Tracy S
    Virology; 2004 Nov; 329(2):381-94. PubMed ID: 15518817
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Coxsackievirus infection of the pancreas: evaluation of receptor expression, pathogenesis, and immunopathology.
    Mena I; Fischer C; Gebhard JR; Perry CM; Harkins S; Whitton JL
    Virology; 2000 Jun; 271(2):276-88. PubMed ID: 10860882
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Virus receptor trap neutralizes coxsackievirus in experimental murine viral myocarditis.
    Lim BK; Choi JH; Nam JH; Gil CO; Shin JO; Yun SH; Kim DK; Jeon ES
    Cardiovasc Res; 2006 Aug; 71(3):517-26. PubMed ID: 16806133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The viral genetic background determines the outcome of coxsackievirus B3 infection in outbred NMRI mice.
    Schmidtke M; Merkle I; Klingel K; Hammerschmidt E; Zautner AE; Wutzler P
    J Med Virol; 2007 Sep; 79(9):1334-42. PubMed ID: 17607777
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Specific interactions of mouse organ proteins with the 5'untranslated region of coxsackievirus B3: potential determinants of viral tissue tropism.
    Cheung PK; Yuan J; Zhang HM; Chau D; Yanagawa B; Suarez A; McManus B; Yang D
    J Med Virol; 2005 Nov; 77(3):414-24. PubMed ID: 16173012
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Soluble recombinant coxsackievirus and adenovirus receptor abrogates coxsackievirus b3-mediated pancreatitis and myocarditis in mice.
    Yanagawa B; Spiller OB; Proctor DG; Choy J; Luo H; Zhang HM; Suarez A; Yang D; McManus BM
    J Infect Dis; 2004 Apr; 189(8):1431-9. PubMed ID: 15073680
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Inhibition of coxsackievirus infection in cardiomyocytes by small dsRNA targeting its cognate coxsackievirus adenovirus receptor.
    Sharma M; Mishra B; Saikia UN; Bahl A; Ratho RK
    Indian J Med Res; 2017 Oct; 146(4):520-527. PubMed ID: 29434067
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Activation of STAT1 transcription factor precedes up-regulation of coxsackievirus-adenovirus receptor during viral myocarditis.
    Ruppert V; Meyer T; Pankuweit S; Jonsdottir T; Maisch B
    Cardiovasc Pathol; 2008; 17(2):81-92. PubMed ID: 18329552
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Immunogenicity of a DNA vaccine for coxsackievirus B3 in mice: protective effects of capsid proteins against viral challenge.
    Kim JY; Jeon ES; Lim BK; Kim SM; Chung SK; Kim JM; Park SI; Jo I; Nam JH
    Vaccine; 2005 Feb; 23(14):1672-9. PubMed ID: 15705471
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Differential macrophage polarization in male and female BALB/c mice infected with coxsackievirus B3 defines susceptibility to viral myocarditis.
    Li K; Xu W; Guo Q; Jiang Z; Wang P; Yue Y; Xiong S
    Circ Res; 2009 Aug; 105(4):353-64. PubMed ID: 19608981
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Antibody-dependent enhancement of coxsackievirus B3 infection of primary CD19+ B lymphocytes.
    Jarasch-Althof N; Wiesener N; Schmidtke M; Wutzler P; Henke A
    Viral Immunol; 2010 Aug; 23(4):369-76. PubMed ID: 20712481
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Comparative analysis of two coxsackievirus B3 strains: putative influence of virus-receptor interactions on pathogenesis.
    Selinka HC; Wolde A; Pasch A; Klingel K; Schnorr JJ; Küpper JH; Lindberg AM; Kandolf R
    J Med Virol; 2002 Jun; 67(2):224-33. PubMed ID: 11992583
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevention of cardiac dysfunction in acute coxsackievirus B3 cardiomyopathy by inducible expression of a soluble coxsackievirus-adenovirus receptor.
    Pinkert S; Westermann D; Wang X; Klingel K; Dörner A; Savvatis K; Grössl T; Krohn S; Tschöpe C; Zeichhardt H; Kotsch K; Weitmann K; Hoffmann W; Schultheiss HP; Spiller OB; Poller W; Fechner H
    Circulation; 2009 Dec; 120(23):2358-66. PubMed ID: 19933937
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The coxsackie-adenovirus receptor (CAR) is used by reference strains and clinical isolates representing all six serotypes of coxsackievirus group B and by swine vesicular disease virus.
    Martino TA; Petric M; Weingartl H; Bergelson JM; Opavsky MA; Richardson CD; Modlin JF; Finberg RW; Kain KC; Willis N; Gauntt CJ; Liu PP
    Virology; 2000 May; 271(1):99-108. PubMed ID: 10814575
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vaccination with coxsackievirus B3 virus-like particles elicits humoral immune response and protects mice against myocarditis.
    Zhang L; Parham NJ; Zhang F; Aasa-Chapman M; Gould EA; Zhang H
    Vaccine; 2012 Mar; 30(13):2301-8. PubMed ID: 22306858
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The role of B lymphocytes in coxsackievirus B3 infection.
    Mena I; Perry CM; Harkins S; Rodriguez F; Gebhard J; Whitton JL
    Am J Pathol; 1999 Oct; 155(4):1205-15. PubMed ID: 10514403
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of coxsackie B virus infection by soluble forms of its receptors: binding affinities, altered particle formation, and competition with cellular receptors.
    Goodfellow IG; Evans DJ; Blom AM; Kerrigan D; Miners JS; Morgan BP; Spiller OB
    J Virol; 2005 Sep; 79(18):12016-24. PubMed ID: 16140777
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.